Risk Factors for Distant Metastasis in T3 T4 Rectal Cancer

被引:3
作者
Tang, Cui [1 ]
Xu, Jinming [1 ]
Lin, Moubin [2 ]
Qiu, Shixiong [1 ]
Wang, Huan [3 ]
Zuo, Xiaoming [4 ]
Liu, Mengxiao [5 ]
Wang, Peijun [6 ,7 ]
机构
[1] Tongji Univ, Yangpu Hosp, Sch Med, Dept Radiol, Shanghai, Peoples R China
[2] Tongji Univ, Yangpu Hosp, Sch Med, Dept Gen Surg, Shanghai, Peoples R China
[3] Tongji Univ, Tongji Hosp, Dept Clin Res Ctr, Sch Med, Shanghai, Peoples R China
[4] Tongji Univ, Yangpu Hosp, Sch Med, Dept Pathol, Shanghai, Peoples R China
[5] Siemens Healthcare Ltd, MR Sci Mkt, Diagnost Imaging, Shanghai, Peoples R China
[6] Tongji Univ, Tongji Hosp, Sch Med, Dept Radiol, Shanghai, Peoples R China
[7] Tongji Univ, Tongji Hosp, Sch Med, Dept Radiol, Shanghai 200065, Peoples R China
关键词
Rectal cancer; extramural vascular invasion; CEA; distant metastasis; risk factors; EXTRAMURAL VASCULAR INVASION; INDEPENDENT PROGNOSTIC-FACTOR; COLORECTAL-CANCER; VENOUS INVASION; TUMOR SIZE; LYMPH-NODES; SURVIVAL; EXPRESSION;
D O I
10.1177/11795549241227423
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Distant metastasis is the leading cause of death in patients with rectal cancer. This study aims to comprehensively analyze the risk factors of distant metastasis in T3 T4 rectal cancer using magnetic resonance imaging (MRI), pathological features, and serum indicators. Methods: The clinicopathological data of 146 cases of T3 T4 rectal cancer after radical resection from January 2015 to March 2023 were retrospectively analyzed. Pre- and postoperative follow-up data of all cases were collected to screen for distant metastatic lesions. Univariate and multivariate Logistic regression methods were used to analyze the relationship between MRI features, pathological results, serum test indexes, and distant metastasis. Results: Of the 146 included patients, synchronous or metachronous distance metastasis was confirmed in 43 (29.4%) cases. The patients' baseline data and univariate analysis showed that mrEMVI, maximum tumor diameter, mr T Stage, pathological N stage, number of lymph node metastasis, cancer nodules, preoperative serum CEA, (Carcinoembryonic antigen) and CA199 were associated with distant metastasis. In the multiple logistic regression model, mrEMVI, pathological N stage, number of lymph node metastasis, maximum tumor diameter, and preoperative serum CEA were identified as independent risk factors for distant metastasis: mrEMVI [odds ratio (OR) = 3.06], pathological N stage (OR = 6.52 for N1 vs N0; OR = 63.47 for N2 vs N0), preoperative serum CEA (OR = 0.27), tumor maximum diameter (OR = 1.03), number of lymph nodes metastasis (OR = 0.62). And, the receiver operating characteristic (ROC) curve was plotted and the area under the curve was calculated (area under the curve [AUC) = 0.817, 95% CI = 0.744-0.890, P < .001]. Conclusions: mrEMVI, pathological N stage, number of lymph node metastasis, maximum tumor diameter and preoperative serum CEA are the independent risk factors for distant metastasis in T3 T4 rectal cancer. A comprehensive analysis of the risk factors for distant metastasis in rectal cancer can provide a reliable basis for formulating individualized treatment strategies, follow-up plans, and evaluating prognosis.
引用
收藏
页数:12
相关论文
共 50 条
[21]   Surgery for Locally Advanced T4 Rectal Cancer: Strategies and Techniques [J].
Helewa, Ramzi M. ;
Park, Jason .
CLINICS IN COLON AND RECTAL SURGERY, 2016, 29 (02) :106-113
[22]   Prognostic Heterogeneity of Endosonographic T3 Rectal Cancer [J].
Esclapez, Pedro ;
Garcia-Granero, Eduardo ;
Flor, Blas ;
Garcia-Botello, Stephanie ;
Cervantes, Andres ;
Navarro, Samuel ;
Lledo, Salvador .
DISEASES OF THE COLON & RECTUM, 2009, 52 (04) :685-691
[23]   Radiotherapy, concomitant protracted-venous-infusion 5-fluorouracil, and surgery for ultrasound-staged T3 or T4 rectal cancer [J].
Mehta, VK ;
Poen, J ;
Ford, J ;
Edelstein, PS ;
Vierra, M ;
Bastidas, AJ ;
Young, H ;
Fisher, G .
DISEASES OF THE COLON & RECTUM, 2001, 44 (01) :52-58
[24]   Clinicopathologic and prognostic factors of patients with T3/T4 colorectal signet ring cell carcinoma: a population-based study [J].
Fan Zhang ;
Boqi Xu ;
Yao Peng ;
Zhongqi Mao .
Journal of Cancer Research and Clinical Oncology, 2023, 149 :9747-9756
[25]   Clinicopathologic and prognostic factors of patients with T3/T4 colorectal signet ring cell carcinoma: a population-based study [J].
Zhang, Fan ;
Xu, Boqi ;
Peng, Yao ;
Mao, Zhongqi .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (12) :9747-9756
[26]   A machine learning-based model for predicting distant metastasis in patients with rectal cancer [J].
Qiu, Binxu ;
Shen, Zixiong ;
Wu, Song ;
Qin, Xinxin ;
Yang, Dongliang ;
Wang, Quan .
FRONTIERS IN ONCOLOGY, 2023, 13
[27]   Impact of D3 lymph node dissection on survival for patients with T3 and T4 colon cancer [J].
Kotake, Kenjiro ;
Mizuguchi, Tomoka ;
Moritani, Konosuke ;
Wada, Osamu ;
Ozawa, Heita ;
Oki, Izumi ;
Sugihara, Kenichi .
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2014, 29 (07) :847-852
[28]   Preoperative radiotherapy, total mesorectal excision and postoperative chemotherapy for T3 and T4 rectal cancer [Praoperative radiotherapie, totale mesorektale exzision und postoperative chemotherapie in der behandlung der T3- und T4-rektumkarzinome] [J].
Fasolini F. ;
Notter M. ;
Wernli M. ;
Stamm B. ;
Aeberhard P. ;
Schlumpf R. .
Coloproctology, 1999, 21 (2) :50-56
[29]   T4 rectal cancer.: Surgery and multimodal therapy [J].
Rau, B ;
Hohenberger, P ;
Gellermann, J ;
Hünerbein, M ;
Hildebrandt, B ;
Schneider, U ;
Riess, H ;
Wust, P ;
Schlag, PM .
CHIRURG, 2002, 73 (02) :147-153
[30]   Efficacy and safety of neoadjuvant chemotherapy with oxaliplatin, 5-fluorouracil, and levofolinate for T3 or T4 stage II/III rectal cancer: the FACT trial [J].
Junichi Koike ;
Kimihiko Funahashi ;
Kazuhiko Yoshimatsu ;
Hajime Yokomizo ;
Hayato Kan ;
Takeshi Yamada ;
Hideyuki Ishida ;
Keiichiro Ishibashi ;
Yoshihisa Saida ;
Toshiyuki Enomoto ;
Kenji Katsumata ;
Masayuki Hisada ;
Hirotoshi Hasegawa ;
Keiji Koda ;
Takumi Ochiai ;
Kazuhiro Sakamoto ;
Hiroyuki Shiokawa ;
Shimpei Ogawa ;
Michio Itabashi ;
Shingo Kameoka .
Cancer Chemotherapy and Pharmacology, 2017, 79 :519-525